NCT03372850View on ClinicalTrials.gov

Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations

PHASE1UnknownINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2018

Conditions
Healthy
Interventions
DRUG

HIP1601

Test Drug

DRUG

HGP1705

Reference Drug

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT03372850 - Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations | Biotech Hunter | Biotech Hunter